This story is from the CurrentWire archive. Coverage details reflect the last time it was updated.
Bacterial nanoplatform reprograms spleen immune cells to help prevent cancer recurrence
A research team led by Professor Yong Taik Lim at the SKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University, have developed an engineered nanoplatform named t-SMC (trained immunity-mediated splenic myelopoiesis converter), which precisely targets the spleen to reverse splenic myelopoiesis toward an antitumoral immune phenotype. The research is published in the journal Advanced Materials.
Phys.org
Published by CurrentWire · First coverage
Compiled by CurrentWire News Desk
Summary based on reporting from Phys.org.
In this story
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Coverage
1 publication is covering this story.
How CurrentWire compiled this story
Phys.org (phys.org), a Tier B publisher, filed this report on . CurrentWire published this page 1 minute later, on .
Filed under General · International · News.
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.